[144] Taysha Gene Therapies, Inc. SEC Filing

Rhea-AI Filing Summary

Taysha Gene Therapies (TSHA) filing a Form 144 notifies intent to sell 27,590 shares of common stock through Maxim Group LLC on 08/21/2025 with an aggregate market value of $79,183.30. The shares were acquired as a RSU award and were vested and settled in stock on 08/21/2025, with the stated consideration being the reporting person’s continued service as an employee. The filing reports 272,794,885 shares outstanding and indicates no securities sold by the reporting person in the prior three months.

Positive

• Source of shares disclosed: Shares were acquired via an RSU award and were vested and settled in stock on 08/21/2025.
• Full transaction details provided: Number of shares (27,590), aggregate market value ($79,183.30), broker (Maxim Group LLC), intended sale date (08/21/2025) and shares outstanding (272,794,885) are all specified.

Negative

• None.

Insights

Securities Analyst

TL;DR: Routine insider sale notice for vested RSUs; size and timing disclosed, no recent sales reported.

The Form 144 indicates a planned sale of 27,590 shares, arising from a vested RSU award settled in stock the same day. The broker is identified as Maxim Group LLC and the intended sale date is 08/21/2025. The filing complies with Rule 144 disclosure requirements and reports no sales by the reporting person over the prior three months. This appears procedural rather than indicative of sudden material developments.

Corporate Governance Expert

TL;DR: Disclosure documents an employee's sale of vested equity; includes required certification about material nonpublic information.

The filer certifies they are unaware of undisclosed material adverse information and the form notes the RSU origin and vesting/settlement details. The signature and attestation language required under the form are present. No governance or compliance exceptions are stated in the content provided.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Maxim Group LLC 300 Park Avenue, 16th Floor New York NY 10022	27590	79183.30	272794885	08/21/2025	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	08/21/2025	RSU Award	Issuer			27590	08/21/2025	Vested grant settled instock; consideration was Reporting Person's continued service as an employee ofthe Issuer.

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the TSHA Form 144 disclose about the planned sale?

The filing discloses intent to sell 27,590 common shares through Maxim Group LLC on 08/21/2025 with aggregate market value of $79,183.30.

How were the shares acquired according to the Form 144 for TSHA?

The shares were acquired as a RSU award and were vested and settled in stock on 08/21/2025.

Does the Form 144 report any sales by the reporting person in the past three months?

The filing states Nothing to Report for securities sold during the past three months by the reporting person.

What outstanding share count does the Form 144 list for TSHA?

The Form 144 lists 272,794,885 shares outstanding.

Who is the broker handling the proposed sale in the TSHA Form 144?

The broker named in the filing is Maxim Group LLC, 300 Park Avenue, 16th Floor, New York, NY 10022.